July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...

(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...

Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...

Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion ...

A steamy shipping glitch has forced Novartis' generics unit to yank a batch of deep vein thrombosis meds from U.S. shelves. Sandoz is recalling one lot of enoxaparin sodium injection single-dose ...

Techdow USA Inc., a division of the Hepalink Group (Techdow USA), has announced its next finished drug product launch, Enoxaparin Sodium (Enoxaparin). This product is expected to launch in June of ...

SAN FRANCISCO (MarketWatch) -- Sanofi-Aventis on Wednesday said the Food and Drug Administration has accepted for review a supplemental new drug application for its Lovenox anticoagulant for the ...

LONDON (Reuters) - Bayer AG has launched its new anticoagulant pill Xarelto in Britain and Germany, pricing the product on a par with Sanofi-Aventis's Lovenox injection, the company said on Thursday.

Enoxaparin (Lovenox) reduces the risk of blood clots in partially paralyzed stroke patients to a greater extent than unfractionated heparin, according to a large-scale multinational study. Researchers ...